{"id":446536,"title":"Notice: Multiple additions to the Prescription Drug List (PDL) [2022-12-22] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T12:10:34.029000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2022-12-22.html?wbdisable=false","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) December 22, 2022 Our file number: 22-113424-10 The purpose of this Notice of Amendment is to notify about the addition of finerenone, lenacapavir, mavacamten, selumetinib, ubrogepant to the Prescription Drug List…","rawSnapshotUrl":"/api/snapshots/raw/446536","browseUrl":"https://replay.healtharchive.ca/job-6/20260103121034/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2022-12-22.html?wbdisable=false#ha_snapshot=446536","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}